Post-Prostate Artery Embolization Hematuria and Clot Passage
You should contact your interventional radiologist or urologist within 24-48 hours for evaluation, as persistent hematuria with clot passage 2 weeks post-PAE, especially lasting 5 days, warrants clinical assessment to rule out complications, though this is likely post-procedural inflammation that will resolve.
Understanding Your Symptoms
The symptoms you're experiencing—intermittent blood in urine (pink discoloration, red drops) and small 5mm clots—are recognized adverse events following prostate artery embolization. While hematuria is a known complication of PAE, the timing and persistence require attention 1, 2.
Expected Post-PAE Course
- Common early symptoms: Hematuria is documented as an adverse event after PAE, typically related to prostatic tissue inflammation and necrosis 1
- Resolution timeline: In patients treated specifically for gross hematuria with PAE, bleeding typically resolves within 48 hours post-procedure 3
- Your timeline concern: At 2 weeks post-procedure with 5 consecutive days of bleeding, you're beyond the typical early resolution window
Risk Assessment
Why This Needs Evaluation (Not Emergency)
Moderate concern indicators:
- Clot passage (5mm) suggests active bleeding source
- Intermittent pattern (sometimes pink, sometimes red, sometimes clear) indicates ongoing but variable bleeding
- Duration of 5 days at 2-week mark is prolonged
Reassuring factors:
- You're able to urinate (not in retention)
- Clots are small (5mm, not obstructing)
- Pattern is intermittent, not continuous gross hematuria
What Could Be Happening
- Most likely: Post-embolization prostatic tissue sloughing and inflammation—this is part of the healing process but can cause bleeding 1, 2
- Possible: Incomplete embolization or recanalization of prostatic vessels
- Less likely but important to exclude: Bladder injury, urinary tract infection, or non-target embolization effects 1
Immediate Management Steps
What You Should Do Now
- Increase fluid intake: Drink 2-3 liters of water daily to help flush clots and dilute urine
- Avoid blood thinners: If you take aspirin, NSAIDs (ibuprofen, naproxen), or other anticoagulants, discuss with your physician about temporary cessation
- Avoid straining: No heavy lifting, vigorous exercise, or straining with bowel movements
- Monitor closely for these warning signs requiring urgent/emergency evaluation:
- Inability to urinate (urinary retention from clot obstruction)
- Continuous bright red bleeding (not just pink or intermittent)
- Large clots that obstruct urine flow
- Fever >38.5°C (101.3°F) suggesting infection
- Dizziness, weakness, or rapid heart rate (suggesting significant blood loss)
When to Seek Care
Within 24-48 hours (non-urgent appointment):
- Your current symptoms warrant clinical evaluation
- Examination should include urinalysis, assessment for infection, and possibly cystoscopy to identify bleeding source 4
- Your provider may perform imaging to assess for complications
Immediately (emergency department):
- Any of the warning signs listed above
- Worsening symptoms or inability to pass urine
What Your Provider Will Likely Do
Expected Evaluation
- History and physical: Characterize bleeding pattern, assess for infection signs, check vital signs
- Urinalysis with microscopy: Differentiate between prostatic bleeding and other sources 4
- Consider cystoscopy: Direct visualization if bleeding source unclear or persistent 5
- Possible imaging: Ultrasound or CT if complications suspected
Treatment Options
- Conservative management: Most cases resolve with hydration and observation 2
- Antibiotics: If urinary tract infection present (reported in 11% of PAE patients) 3
- Bladder irrigation: For clot retention or continuous bleeding (though you're not at this point yet)
- Rarely needed: Repeat embolization or surgical intervention for persistent bleeding 6
Context from Evidence
Studies of PAE for hematuria show that when PAE is performed specifically to treat gross prostatic bleeding, 87.5% of patients have resolution within 48 hours 3. In another series treating hematuria with PAE, 85% remained hematuria-free at 3 months, with 80% success at 12 months 6. Your bleeding at 2 weeks is outside this typical pattern and merits evaluation, though it may still represent delayed tissue sloughing rather than a complication requiring intervention.
Key point: While hematuria is an expected adverse event after PAE 1, 2, the persistence and pattern you describe warrant clinical assessment to ensure appropriate healing and rule out treatable complications. Most cases will resolve with conservative management, but evaluation is prudent to avoid missing something that needs intervention.